anmelden
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call
Werte in diesem Artikel
MISSISSAUGA, ON, March 8, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) ("Cipher" or the "Company") today announced that it will release its financial results for the fourth quarter and full year of 2023 after the market close on Thursday, March 14, 2024. The Company will also hold a conference call on Friday, March 15 at 8:30 ET to discuss the results and corporate developments.
CONFERENCE CALL DETAILS
DATE: | March 15, 2024 |
TIME: | 8:30AM |
DIAL-IN NUMBER: | 416-764-8650 or 888-664-6383 |
REPLAY: | 416-764-8677 or 888-390-0541 Code: 128854# |
Expires: March 22, 2024 | |
WEBCAST: | https://app.webinar.net/YqROVOGVJeP |
Cipher Pharmaceuticals (TSX: CPH, OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
Ausgewählte Hebelprodukte auf Cipher Pharmaceuticals
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cipher Pharmaceuticals
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Cipher Pharmaceuticals Aktie News
Cipher Pharmaceuticals Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cipher Pharmaceuticals nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
Keine Analysen gefunden.
